Archive for April, 2021
In the third week of April 2021, various news media announced that the UK government would be pressing for the development of an ‘anti-viral pill’, which could offer easier and faster support for people infected with a variant or the original wild type Sars-Cov-2 virus. Read the rest of this entry »
As the UK progresses towards the current milestones indicated by the government regarding the changing of social restrictions and the possible development of a different societal set of norms, either temporary or prolonged, it is time to start to categorise risk and future health care plans as our work (in health provision) will be in large part shaped by these developments.
Clearly, the aim of all countries needs to be focussed on the setting up of a future set of plans, strategies to mitigate future zoonotic migrations. But why stop there?
People, environments, and governments are undergoing serious challenges to their futures and part of this hinges on the development of a sustainable approach to health generation. The last 12 months has exposed international vulnerabilities, poor risk management and the associated consequences of a very small pathogen finding a willing host for its journey around the world. Read the rest of this entry »